Digoxin reduces the risk of heart failure hospitalization in heart failure patients with reduced ejection fraction; this study looks at the efficacy of digoxin in patients with preserved ejection fraction.
In this video, AJM Editor-in-Chief Dr. Joseph S. Alpert explains “Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction,” which appears in the October 2020 issue of AJM, available at amjmed.com.
